Completed
A Study of Enzalutamide and LY3023414 in Men with Prostate Cancer
I6A-MC-CBBD - ClinicalTrials.gov - NCT02407054
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.
How long will I be in the trial?
Your participation could last up to 56 days or longer if you are tolerating the study drug and your study doctor thinks your condition is stable or improving.
Completed
A Study of Enzalutamide and LY3023414 in Men with Prostate Cancer
I6A-MC-CBBD - ClinicalTrials.gov - NCT02407054
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.
How long will I be in the trial?
Your participation could last up to 56 days or longer if you are tolerating the study drug and your study doctor thinks your condition is stable or improving.
Key Requirements
Age :
18+
Sex:
Male
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
Male
Participants must
Participant must have diagnosis of prostate cancer
Participant must have metastatic disease
Participant must have completed and failed prior abiraterone treatment
Participant must be surgically or medically castrated
Participant must be able to swallow the study drug (pills) whole
Participants must NOT
Participant must not have had prior treatment with chemotherapy or enzalutamide
Participant must not have known brain metastases or uncontrolled hypertension
Participant must not have insulin-dependent diabetes mellitus, however participants with type 2 diabetes mellitus may be eligible
Participant must not have an active, known fungal, bacterial, and/or known viral infection
Trial Summary
Conditions the trial is for
Prostate Cancer
What the trial is testing?
LY3023414 + Enzalutamide, Placebo + Enzalutamide
Could I receive a Placebo?
yes
Enrollment Goal
144
Trial Dates
April 2015 - April 2020
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
Male
Participants must
Participant must have diagnosis of prostate cancer
Participant must have metastatic disease
Participant must have completed and failed prior abiraterone treatment
Participant must be surgically or medically castrated
Participant must be able to swallow the study drug (pills) whole
Participants must NOT
Participant must not have had prior treatment with chemotherapy or enzalutamide
Participant must not have known brain metastases or uncontrolled hypertension
Participant must not have insulin-dependent diabetes mellitus, however participants with type 2 diabetes mellitus may be eligible
Participant must not have an active, known fungal, bacterial, and/or known viral infection
Trial Summary
Conditions the trial is for
Prostate Cancer
What the trial is testing?
LY3023414 + Enzalutamide, Placebo + Enzalutamide
Could I receive a Placebo?
yes
Enrollment Goal
144
Trial Dates
April 2015 - April 2020
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Prostate Cancer Resources
